Lipid function at synapses

Current Opinion in Neurobiology

Volumn 20, Issue 5, 2010, Pages 543-549

  Davletov, Bazbek ^a   Montecucco, Cesare ^b  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDASE; ION CHANNEL; LIPID; LIPOPROTEIN LIPASE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; SNARE PROTEIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ALZHEIMER DISEASE; BRAIN NERVE CELL; CATALYSIS; DEGENERATIVE DISEASE; ENDOCYTOSIS; ENZYME ACTIVITY; EXOCYTOSIS; HUMAN; LIPID METABOLISM; METABOLITE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SYNAPSE;

ANIMALS; CELL FUSION; EXOCYTOSIS; HUMANS; LIPID METABOLISM; MEMBRANE LIPIDS; NEURODEGENERATIVE DISEASES; SYNAPSES; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION;

EID: 77957018205     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2010.06.008     Document Type: Review

References (54)

1. Zhai R.G., Bellen H.J. The architecture of the active zone in the presynaptic nerve terminal. Physiology (Bethesda) 2004, 19:262-270.
2. Sudhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323:474-477.
3. Shin O.H., Xu J., Rizo J., Sudhof TC Differential but convergent functions of Ca2+ binding to synaptotagmin-1 C2 domains mediate neurotransmitter release. Proc Natl Acad Sci U S A 2009, 106:16469-16474.
4. Fukata Y., Fukata M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat Rev Neurosci 2010, 11:161-175.
5. Buchwald B., Zhang G., Vogt-Eisele A.K., Zhang W., Ahangari R., Griffin J.W., Hatt H., Toyka K.V., Sheikh K.A. Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiol Dis 2007, 28:113-121.
6. Prinetti A., Chigorno V., Prioni S., Loberto N., Marano N., Tettamanti G., Sonnino S. Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 2001, 276:21136-21145.
7. Devaux P.F., Morris R. Transmembrane asymmetry and lateral domains in biological membranes. Traffic 2004, 5:241-246.
8. Churchward M.A., Coorssen J.R. Cholesterol, regulated exocytosis and the physiological fusion machine. Biochem J 2009, 423:1-14.
9. Helms J.B., Zurzolo C. Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic 2004, 5:247-254.
10. Takamori S., Holt M., Stenius K., Lemke E.A., Grønborg M., Riedel D., Urlaub H., Schenck S., Brügger B., Ringler P., et al. Molecular anatomy of a trafficking organelle. Cell 2006, 127:831-846.
11. Thiele C., Hannah M.J., Fahrenholz F., Huttner W.B. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2000, 2:42-49.
12. Piomelli D., Astarita G., Rapaka R A neuroscientist's guide to lipidomics. Nat Rev Neurosci 2007, 8:743-754.
13. Yang Q., Guo Y., Li L., Hui S.W. Effects of lipid headgroup and packing stress on poly(ethylene glycol)-induced phospholipid vesicle aggregation and fusion. Biophys J 1997, 73:277-282.
14. Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443:651-657.
15. Di Paolo G., Moskowitz H.S., Gipson K., Wenk M.R., Voronov S., Obayashi M., Flavell R., Fitzsimonds R.M., Ryan T.A., De Camilli P. Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking. Nature 2004, 431:415-422.
16. Chernomordik L.V., Zimmerberg J., Kozlov M.M. Membranes of the world unite!. J Cell Biol 2006, 175:201-207.
17. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
18. Brown W.J., Chambers K., Doody A. Phospholipase A2 (PLA2) enzymes in membrane trafficking: mediators of membrane shape and function. Traffic 2003, 4:214-221.
19. Bader M.F., Vitale N. Phospholipase D in calcium-regulated exocytosis: lessons from chromaffin cells. Biochim Biophys Acta 2009, 1791:936-941.
20. Rigoni M., Caccin P., Gschmeissner S., Koster G., Postle A.D., Rossetto O., Schiavo G., Montecucco C. Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures. Science 2005, 310:1678-1680.
21. Darios F., Wasser C., Shakirzyanova A., Giniatullin A., Goodman K., Munoz-Bravo J.L., Raingo J., Jorgacevski J., Kreft M., Zorec R., et al. Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis. Neuron 2009, 62:683-694.
22. Brash A.R. Arachidonic acid as a bioactive molecule. J Clin Invest 2001, 107:1339-1345.
23. Wolf B.A., Pasquale S.M., Turk J. Free fatty acid accumulation in secretagogue-stimulated pancreatic islets and effects of arachidonate on depolarization-induced insulin secretion. Biochemistry 1991, 30:6372-6379.
24. Negre-Aminou P., Pfenninger K.H. Arachidonic acid turnover and phospholipase A2 activity in neuronal growth cones. J Neurochem 1993, 60:1126-1136.
25. Tse C.K., Dolly J.O., Hambleton P., Wray D., Melling J. Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur J Biochem 1982, 122:493-500.
26. Megighian A., Rigoni M., Caccin P., Zordan M.A., Montecucco C. A lysolecithin/fatty acid mixture promotes and then blocks neurotransmitter release at the Drosophila melanogaster larval neuromuscular junction. Neurosci Lett 2007, 416:6-11.
27. Rickman C., Davletov B. Arachidonic acid allows SNARE complex formation in the presence of Munc18. Chem Biol 2005, 12:545-553.
28. Darios F., Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006, 440:813-817.
29. Piomelli D. Arachidonic acid in cell signaling. Curr Opin Cell Biol 1993, 5:274-280.
30. Wierda K.D., Toonen R.F., de Wit H., Brussaard A.B., Verhage M. Interdependence of PKC-dependent and PKC-independent pathways for presynaptic plasticity. Neuron 2007, 54:275-290.
31. Micheva K.D., Holz R.W., Smith S.J. Regulation of presynaptic phosphatidylinositol 4,5-biphosphate by neuronal activity. J Cell Biol 2001, 154:355-368.
32. Hammond G.R., Dove S.K., Nicol A., Pinxteren J.A., Zicha D., Schiavo G. Elimination of plasma membrane phosphatidylinositol (4,5)-bisphosphate is required for exocytosis from mast cells. J Cell Sci 2006, 119:2084-2094.
33. Guenifi A., Simonsson E., Karlsson S., Ahren B., Abdel-Halim S.M. Carbachol restores insulin release in diabetic GK rat islets by mechanisms largely involving hydrolysis of diacylglycerol and direct interaction with the exocytotic machinery. Pancreas 2001, 22:164-171.
34. Sheu L., Pasyk E.A., Ji J., Huang X., Gao X., Varoqueaux F., Brose N., Gaisano H.Y. Regulation of insulin exocytosis by Munc13-1. J Biol Chem 2003, 278:27556-27563.
35. Rahman M.A., Ashton A.C., Meunier F.A., Davletov B.A., Dolly J.O., Ushkaryov Y.A. Norepinephrine exocytosis stimulated by alpha-latrotoxin requires both external and stored Ca2+ and is mediated by latrophilin. G proteins and phospholipase C. Philos Trans R Soc Lond B Biol Sci 1999, 354:379-386.
36. Huang F.D., Woodruff E., Mohrmann R., Broadie K. Rolling blackout is required for synaptic vesicle exocytosis. J Neurosci 2006, 26:2369-2379.
37. Vijayakrishnan N., Broadie K. Temperature-sensitive paralytic mutants: insights into the synaptic vesicle cycle. Biochem Soc Trans 2006, 34:81-87.
38. Lam A.D., Tryoen-Toth P., Tsai B., Vitale N., Stuenkel E.L. SNARE-catalyzed fusion events are regulated by Syntaxin1A-lipid interactions. Mol Biol Cell 2008, 19:485-497.
39. Ichikawa S., Walde P. Phospholipase D-mediated aggregation, fusion, and precipitation of phospholipid vesicles. Langmuir 2004, 20:941-949.
40. Mitsutake S., Igarashi Y. Transbilayer movement of ceramide in the plasma membrane of live cells. Biochem Biophys Res Commun 2007, 359:622-627.
41. Montes L.R., Ibarguren M., Goñi F.M., Stonehouse M., Vasil M.L., Alonso A. Leakage-free membrane fusion induced by the hydrolytic activity of PlcHR(2), a novel phospholipase C/sphingomyelinase from Pseudomonas aeruginosa. Biochim Biophys Acta 2007, 1768:2365-2372.
42. Rohrbough J., Rushton E., Palanker L., Woodruff E., Matthies H.J., Acharya U., Acharya J.K., Broadie K. Ceramidase regulates synaptic vesicle exocytosis and trafficking. J Neurosci 2004, 24:7789-7803.
43. Camoletto P.G., Vara H., Morando L., Connell E., Marletto F.P., Giustetto M., Sassoè-Pognetto M., Van Veldhoven P.P., Ledesma M.D. Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18. PLoS One 2009, 4:e5310.
44. Lovinger D.M. Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol 2008, 435-477.
45. Kress M., Kuner R. Mode of action of cannabinoids on nociceptive nerve endings. Exp Brain Res 2009, 196:79-88.
46. Bosier B., Muccioli G.G., Hermans E., Lambert D.M. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities. Biochem Pharmacol 2010, 80:1-12.
47. Piomelli D. The ligand that came from within. Trends Pharmacol Sci 2001, 22:17-19.
48. Fantini J., Barrantes F.J. Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta 2009, 1788:2345-2361.
49. Farooqui A.A., Horrocks L.A. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist 2006, 12:245-260.
50. Lane R.M., Farlow M.R. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 2005, 46:949-968.
51. Broersen K., van den Brink D., Fraser G., Goedert M., Davletov B. Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry 2006, 45:15610-15616.
52. Sharon R., Bar-Joseph I., Frosch M.P., Walsh D.M., Hamilton J.A., Selkoe D.J. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 2003, 37:583-595.
53. Klivenyi P., Beal M.F., Ferrante R.J., Andreassen O.A., Wermer M., Chin M.R., Bonventre J.V. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J Neurochem 1998, 71:2634-2637.
54. Adibhatla R.M., Hatcher J.F. Altered lipid metabolism in brain injury and disorders. Subcell Biochem 2008, 48:nihpa41041.